Audio

Inside Brookfield Asset Management: Deploying $11 billion in India in a pandemic year

Inside Brookfield Asset Management: Deploying $11 billion in India in a pandemic year

How to build a unicorn in 6 years

How to build a unicorn in 6 years

Is Sputnik V the shot in the arm India needs?

Is Sputnik V the shot in the arm India needs?

A snapshot of the 12th Anniversary Special

A snapshot of the 12th Anniversary Special

AU Small Finance's Sanjay Agarwal shows financial inclusion can be a viable business

AU Small Finance's Sanjay Agarwal shows financial inclusion can be a viable business

  • Inside our latest edtech issue

    Inside our latest edtech issue

    Sequoia Capital bet big on education technology—ed tech—with over a dozen investments, including in industry giants Byju's and Unacademy. Forbes India' Rajiv Singh unpacks the cover story of the fortnight

  • Inside our 2021 investment special issue

    Inside our 2021 investment special issue

    A peek into our 2021 Investment Special where we dissect and analyse the parameters that will shape investment strategies for the new financial year. Forbes India's Salil Panchal and Samar Srivastava take you through what you can expect in the new issue which is on stands now

  • Inside Forbes India Best Employer 2021 in association with Kincentric

    Inside Forbes India Best Employer 2021 in association with Kincentric

    In the second annual Best Employer issue of Forbes India, the focus was on how the companies navigated the Covid-19 pandemic, making the well being of their employees a priority. Monica Bathija walks you through the process of choosing the best from the Kincentric survey and putting the issue together

  • Inside Forbes India Leadership Awards 2021

    Inside Forbes India Leadership Awards 2021

    After the crucial year that was, the 10th edition of Forbes India Leadership Awards 2021 (FILA 2020) commemorates the leaders that stood out for taking the lead on tackling the Covid-19 challenge, steering with grit and vision and looking after their people and businesses. Salil Panchal takes you through what went on behind the scenes in putting our annual flagship issue together

  • Regional Goliaths: Inside the Davids of India taking on the Goliaths

    Regional Goliaths: Inside the Davids of India taking on the Goliaths

    Local players turned into regional brands and are now are shedding their avatars of being the little guy and are taking over larger MNC rivals in the regions they operate in. Cover story author and special package anchor Rajiv Singh takes you through the journey of a clutch of these regional brands whose stories you will find in our latest issue

  • Inside 'unicorn hunters' Accel India's VC play, and our PE/VC special

    Inside 'unicorn hunters' Accel India's VC play, and our PE/VC special

    How Accel India sniffs out good opportunities early, invests in entrepreneurs' passion, and leads them to unicorn status. Cover story author Rajiv Singh calls Accel India 'unicorn hunters', where the founding partners bring their entrepreneurial experience to investing. Forbes India's Pooja Sarkar speaks about Apollo Global's big play in distressed assets in India and why it will eye big PE deals going forward

  • Recognising the unsung heroes of 2020

    Recognising the unsung heroes of 2020

    As life as we knew it came to a standstill in 2020, we capture both the spirit of innovation that prevailed in India during the pandemic, and acknowledge the various unsung heroes of Covid-19—from doctors to nurses, women of SHGs, municipal workers and ambulance drives, among so many others, who put their safety at stake to keep others safe

  • Inside Zydus Cadila's Covid-19 vaccine—ZyCov-D—play

    Inside Zydus Cadila's Covid-19 vaccine—ZyCov-D—play

    It took them a record 10 months to develop a H1N1 vaccine. Now Sharvil Patel, managing director, and his team at Zydus Cadila are trying to bring a Covid-19 vaccine by March 2021. Manu Balachandran and Divya Shekhar who have been closely following the vaccine race and India's play in it, take you behind the scenes of the ongoings at the Ahmedabad-based pharmaceutical

  • Podcast: Why Hyderabad's Biological E could be the dark horse in India's vaccine race

    Podcast: Why Hyderabad's Biological E could be the dark horse in India's vaccine race

    Forbes India's Manu Balachandran and Divya Shekhar take a jab at why this southern company, which may be a few laps behind the bigwigs in vaccine trials, could make up for lost time in its ability to scale. Will it play a big role in vaccinating India? Find out on this episode

  • Inside Forbes India's philanthropy special

    Inside Forbes India's philanthropy special

    Cover story author Divya Shekhar talks about how Covid-19 has helped rewrite the gospels of charity in India, engaging more than just billionaires

  • Podcast: The 100 Richest Indians 2020

    Podcast: The 100 Richest Indians 2020

    In a year that threw most projections out for a toss, some Indians managed to turn the tide. Many others didn't. Listen to Forbes India's Samar Srivastava detail the most interesting wins, losses and trends among India's billionaires from the Forbes India Rich List issue, which is now on stands